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Background
The aim of current work was to produce recombinant
soluble CCR5 and CXCR4 chemokine receptors that
could be used in screening of potential HIV-1 inhibitors.
Methods
Recombinant DNA constructs were produced by using
polymerase chain reaction (PCR) technique and cloning.
Proteins were expressed in bacteria and purified using
immobilized metal ion affinity chromatography. To vali-
date functionality of the recombinant proteins immuno-
precipitation, immunblot and ELISA assays were
performed.
Results
We designed recombinant soluble CCR5 and CXCR4
proteins where functionally important regions of native
receptors were connected with artificial linkers. These
proteins were expressed in E.coli Origami 2(DE3) cells,
refolded and purified. We have shown that recombinant
proteins are functionally similar to native receptors
s i n c et h e yb i n dt os p e c i f i ca n t i - C C R 5a n da n t i - C X C R 4
antibodies in immunoblot, immunoprecipitation and
ELISA. Using the recombinant proteins for immuniza-
tion we have obtained specific rabbit polyclonal serum.
Finally, we established a competitive ELISA assay to
search for the inhibitors of antigen and antibody bind-
ing. By applying this assay we perfomed screening of
combinative drug library and found potential inhibitors.
Discussion
It is well known that CCR5 and CXCR4 chemokine
receptors play a central role in the mechanism by which
HIV binds to and enters white blood cells, and therefore
represent key targets in the search for effective novel
treatments for HIV infection and AIDS. The current
results indicate that recombinant soluble chemokine
receptors are functionally active and can be used in
screening of potential HIV-1 inhibitors.
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